Skip to main content
Division of Cardiovascular Medicine Division of Cardiovascular Medicine
Beacon Logo
BEACON
Bioinformatics, Epidemiology, and Lp(a) Center for Research and InnOvatioN

Publications

Access our latest research and findings.

dolphin playing with Lp(a) ball

 

Publications / Original Research

  1. Bhatia HS, Trainor P, Carlisle S, Tsai MY, Criqui MH, DeFilippis A, Tsimikas S. Aspirin and Cardiovascular Risk in Individuals With Elevated Lipoprotein(a): The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2024 Feb 6;13(3):e033562. doi:[10.1161/JAHA.123.033562](https://doi.org/10.1161/JAHA.123.033562). Epub 2024 Jan 31. PMID: 38293935. PMCID: PMC11056170. 

  2. Bhatia HS, Wandel S, Willeit P, Lesogor A, Bailey K, Ridker PM, Nestel P, Simes J, Tonkin A, Schwartz GG, Colhoun H, Wanner C, Tsimikas S. Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis. Circulation. 2025 Jan 28;151(4):312-321. doi:[10.1161/CIRCULATIONAHA.124.069556](https://doi.org/10.1161/CIRCULATIONAHA.124.069556). Epub 2024 Nov 4. PMID: 39492722. PMCID: PMC11771346.  

  3. Birs AS, Kao AS, Silver E, Adler ED, Taub PR, Wilkinson MJ. Burden of atherogenic lipids and association with cardiac allograft vasculopathy in heart transplant recipients. J Clin Lipidol. 2025 Jan-Feb;19(1):134-145. doi:[10.1016/j.jacl.2024.10.005](https://doi.org/10.1016/j.jacl.2024.10.005). Epub 2024 Nov 13. PMID: 39542809. 

  4. Bhatia HS, Dweck MR, Craig N, Capoulade R, Pibarot P, Trainor PJ, Whelton SP, Rikhi R, Lidani KCF, Post WS, Tsai MY, Criqui MH, Shapiro MD, Budoff MJ, DeFilippis AP, Thanassoulis G, Tsimikas S. Oxidized Phospholipids and Calcific Aortic Valvular Disease. J Am Coll Cardiol. 2024 Dec 17;84(25):2430-2441. doi:[10.1016/j.jacc.2024.08.070](https://doi.org/10.1016/j.jacc.2024.08.070). Epub 2024 Nov 15. PMID: 39545902. 

  5. Aggarwal R, Bhatt DL, Bonaca MP, Deck C, Lesogor A, Patel MR, Stroes ESG, Taub PR, Windecker S. Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States population. Am J Prev Cardiol. 2025 Mar 8;22:100957. doi:[10.1016/j.ajpc.2025.100957](https://doi.org/10.1016/j.ajpc.2025.100957). Epub 2025 Mar 8. PMID: 40230889. PMCID: PMC11995105. 

  6. Rikhi R, Haidar A, Bhatia HS, Beam K, McParland J, Kazibwe R, Chevli P, Schaich CL, Sanghavi M, Shapiro MD. Association of lipoprotein(a) and diabetes in primary prevention of coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2025 May;404:119179. doi:[10.1016/j.atherosclerosis.2025.119179](https://doi.org/10.1016/j.atherosclerosis.2025.119179). Epub 2025 Mar 27. PMID: 40179714. 

  7. Ellberg CC, Bal K, Duran E, Criqui MH, Shapiro MD, Bhatia HS. Disparities in statin use following identification of coronary artery calcium. Am J Prev Cardiol. 2025 Apr 11;22:100990. doi:[10.1016/j.ajpc.2025.100990](https://doi.org/10.1016/j.ajpc.2025.100990). Epub 2025 Apr 11. PMID: 40290415. PMCID: PMC12022484. 

  8. Taub PR, Gutierrez A, Wewers D, Garcia Cantu E, Cao H, Deck C, Lesogor A, Ott D, Mena-Madrazo J, Zang X, Wright RS. Safety and Lipid-Lowering Efficacy of Inclisiran Monotherapy in Patients without ASCVD: The VICTORION-Mono Randomized Clinical Trial. J Am Coll Cardiol. 2025 Jul 22;86(3):196-208. doi:[10.1016/j.jacc.2025.04.049](https://doi.org/10.1016/j.jacc.2025.04.049). Epub 2025 May 5. PMID: 40392667. 

  9. Kermanshahchi J, Kao AS, Ellberg CC, Duran E, Criqui MH, Shapiro MD, Bhatia HS. First presentation of atherosclerotic cardiovascular disease in previously healthy individuals. Prog Cardiovasc Dis. 2025 Sep-Oct;92:153-158. doi:[10.1016/j.pcad.2025.05.004](https://doi.org/10.1016/j.pcad.2025.05.004). Epub 2025 May 14. PMID: 40379073.  

  10. Razavi AC, Richardson LC, Coronado F, Vesper HW, Lyle A, Bhatia HS, Tsimikas S, Quyyumi AA, Vaccarino V, Eapen DJ, Isiadinso I, Mehta A, Yadalam AK, Osei J, Jacobson TA, Yao Z, Dzaye O, Martin SS, Nasir K, Shapiro MD, Blaha MJ, Whelton SP, Blumenthal RS, Sperling LS. Prevalence and Correlates of Lipoprotein(a) Testing in a Diverse Cohort of U.S. Adults. JACC Adv. 2025 Jun;4(6 Pt 1):101826. doi:[10.1016/j.jacadv.2025.101826](https://doi.org/10.1016/j.jacadv.2025.101826). Epub 2025 May 30. PMID: 40570403.  

  11. Bhatia HS, Ambrosio M, Razavi AC, Alebna PL, Yeang C, Spitz JA, Patel J, Tsai MY, Sperling L, Shapiro MD, Tsimikas S, Mehta A. AHA PREVENT Equations and Lipoprotein(a) for Cardiovascular Disease Risk: Insights From MESA and the UK Biobank. JAMA Cardiol. 2025 Aug 1;10(8):810-818. doi:[10.1001/jamacardio.2025.1603](https://doi.org/10.1001/jamacardio.2025.1603). Epub 2025 Jun 4. PMID: 40465279. PMCID: PMC12138797. 

  12. Hanif M, Khan LA, Kulkarni A, Bhatia HS, Wilkinson MJ, Rashid AM, Chew NWS, Banerjee S, Butler J, Shapiro MD, Khan MS. Global lipoprotein (a) testing trends from 2015 to 2023. Am Heart J. 2025 Nov;289:171-179. doi:[10.1016/j.ahj.2025.06.010](https://doi.org/10.1016/j.ahj.2025.06.010). Epub 2025 Jun 21. PMID: 40550301. 

  13. Kao AS, Kermanshahchi J, Khosrowjerdi S, Razavi AC, Levene J, Reyes M, Garg P, Longstreth WT Jr, Rannikmae K, Sudlow C, Tsai M, Tsimikas S, Saeed A, Bhatia HS. Demographics of lipoprotein(a) and stroke: The UK biobank. Am J Prev Cardiol. 2025 Jun 29;23:101055. doi:[10.1016/j.ajpc.2025.101055](https://doi.org/10.1016/j.ajpc.2025.101055). Epub 2025 Jun 29. PMID: 40687939. PMCID: PMC12273577.  

  14. McCormick D, Taub PR, Carter J, Moreo K, Heggen CL. Implementation of a nonstatin prior authorization checklist for patients with hypercholesterolemia: In 2 community health care systems. J Manag Care Spec Pharm. 2025 Jul;31(7):723-728. doi:[10.18553/jmcp.2025.31.7.723](https://doi.org/10.18553/jmcp.2025.31.7.723). PMID: 40577037. PMCID: PMC12204327.  

  15. Nurmohamed NS, Ngo-Metzger Q, Taub PR, Ray KK, Figtree GA, Bonaca MP, Hsia JA, Angadageri S, Earls JP, Rodriguez F, Sandhu AT, Min JK, Hoffmann U, Maron DJ, Bhatt DL. First myocardial infarction: risk factors, symptoms, and medical therapy. Eur Heart J. 2025 Oct 7;46(38):3762-3772. doi:[10.1093/eurheartj/ehaf390](https://doi.org/10.1093/eurheartj/ehaf390). Epub 2025 Jul 3. PMID: 40605456. PMCID: PMC12500329. 

  16. Razavi AC, Bhatia HS, Dardari ZA, Mehta A, Nasir K, Blankstein R, Isiadinso I, Quyyumi AA, Vaccarino V, Fialkow JA, Khoury MJ, Coronado F, Budoff MJ, Blumenthal RS, Whelton SP, Mortensen MB, Sperling LS, Matsushita K, Blaha MJ, Dzaye O. Family History of Premature Atherosclerotic Cardiovascular Disease and Lipoprotein(a) Levels: A Multi Cohort Analysis. Eur J Prev Cardiol. 2026 Feb 18;33(3):443-445. doi:[10.1093/eurjpc/zwaf392](https://doi.org/10.1093/eurjpc/zwaf392). Epub 2025 Jul 12. PMID: 40624918. PMCID: PMC13333244.  

  17. Razavi AC, Chen J, Yang W, Sha D, Dzaye O, Bhatia HS, Tsimikas S, Lash JP, Kansal M, Rincon-Choles H, Vaccarino V, Jacobson TA, Budoff MJ, Blumenthal RS, Whelton SP, Sperling LS, Blaha MJ, He J, CRIC Study Investigators. Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort. JACC Adv. 2025 Sep;4(9):102068. doi:[10.1016/j.jacadv.2025.102068](https://doi.org/10.1016/j.jacadv.2025.102068). Epub 2025 Aug 19. PMID: 40839904.  

  18. Ramsis M, Naguib M, Dzotsi M, Wilkinson M, Mahmud E, Taub P, Bhatia HS. Lipoprotein(a) Testing Trends in the United States 2015-2024: An Analysis of 300 Million Individuals. JACC Adv. 2025 Nov;4(11 Pt 1):102205. doi:[10.1016/j.jacadv.2025.102205](https://doi.org/10.1016/j.jacadv.2025.102205). Epub 2025 Sep 23. PMID: 40992240. PMCID: PMC12495319. 

  19. Davis JR, Razavi AC, Ellberg CC, Blaha MJ, Criqui MH, Bhatia HS. Utility of coronary artery calcium scoring in low-risk patients: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Prev Cardiol. 2025 Oct 13;24:101329. doi:[10.1016/j.ajpc.2025.101329](https://doi.org/10.1016/j.ajpc.2025.101329). Epub 2025 Oct 13. PMID: 41159137. PMCID: PMC12557561.  

  20. Bhatia HS, McParland J, Rikhi R, Tsai M, Szklo M, Tsimikas S, Yeang C, Shapiro MD. Association of lipoprotein (a) and interleukin-6 with cardiovascular risk: MESA and UK biobank. J Am Coll Cardiol. 2025 Nov 25;86(21):2000-2013. doi:[10.1016/j.jacc.2025.08.101](https://doi.org/10.1016/j.jacc.2025.08.101). Epub 2025 Nov 10. PMID: 41217319. PMCID: PMC13333245. 

  21. Bhatia HS, Cuomo R, Ramsis M, Mahmud E, Taub P, Wilkinson MJ. Impact of PCSK9 inhibitors on lipoprotein(a) levels: a multi-centre study. Eur J Prev Cardiol. 2025 Nov 18:zwaf734. doi:[10.1093/eurjpc/zwaf734](https://doi.org/10.1093/eurjpc/zwaf734). Epub 2025 Nov 18. PMID: 41253688. PMCID: PMC13361851.  

  22. Naguib M, Meyer BC, Felipe F, Cuomo RE, Wilkinson M, Mahmud E, Taub P, Bhatia HS, Ramsis M. Lipoprotein (a) Testing Trends in Young Ischemic Stroke Patients from 2015-2024: An Analysis of 188,000 Individuals. J Stroke Cerebrovasc Dis. 2026 Jan;35(1):108513. doi:[10.1016/j.jstrokecerebrovasdis.2025.108513](https://doi.org/10.1016/j.jstrokecerebrovasdis.2025.108513). Epub 2025 Dec 1. PMID: 41338528. PMCID: PMC13361849.  

  23. Raygani S, Sykes AV, Sanchez AP, Witztum JL, Wilkinson MJ. Therapeutic Plasma Exchange and Evinacumab for Homozygous Familial Hypercholesterolemia. JACC Case Rep. 2026 Feb 11;31(6):106407. doi:[10.1016/j.jaccas.2025.106407](https://doi.org/10.1016/j.jaccas.2025.106407). Epub 2025 Dec 10. PMID: 41369603. PMCID: PMC12905687. [Case report]  

  24. Razavi AC, Dzaye O, Bhatia HS, Vaccarino V, Mehta A, Rotter JI, Guo X, Taylor KD, Yao J, Li X, Rich SS, Budoff MJ, Tsai MY, Blankstein R, Shapiro MD, Nasir K, Tsimikas S, Blumenthal RS, Whelton SP, Blaha MJ, Sperling LS. Modeling benefit of aspirin according to Lp (a) and coronary artery calcium: MESA. JACC Cardiovasc Imaging. 2026 Jun;19(6):774-776. doi:[10.1016/j.jcmg.2025.12.008](https://doi.org/10.1016/j.jcmg.2025.12.008). Epub 2026 Jan 30. PMID: 41615367. PMCID: PMC13367518. 

  25. Reyes MP, Razavi AC, Bhatia HS. Association of Lipoprotein (a) with ASCVD Risk in Women by Menopausal Status: the UK Biobank. Am J Prev Cardiol. 2026 Apr;26:101465. doi:[10.1016/j.ajpc.2026.101465](https://doi.org/10.1016/j.ajpc.2026.101465). Epub 2026 Feb 6. PMID: 42006444. PMCID: PMC13084097.  

  26. Kazibwe R, Schaich CL, Chevli PA, Kingsley JA, Mirzai S, Namutebi JH, Ahmad MI, Mehta A, Bhatia HS, Paukner M, Rikhi R, Michos ED, Shapiro MD. Lipoprotein (a), Insulin Resistance, and Cardiovascular Disease in the UK Biobank. J Am Heart Assoc. 2026 Feb 17;15(4):e042361. doi:[10.1161/JAHA.125.042361](https://doi.org/10.1161/JAHA.125.042361). Epub 2026 Feb 11. PMID: 41669947. PMCID: PMC13055481.  

  27. Chevli PA, Mirzai S, Kazibwe R, Kingsley J, Wood AC, Yeboah J, Slipczuk L, Mehta A, Bhatia HS, Pandey A, Shapiro MD. Circulating Ketone Bodies and Incident Cardiovascular Outcomes and Mortality: Insights From the UK Biobank. J Am Heart Assoc. 2026 Mar 3;15(5):e042582. doi:[10.1161/JAHA.125.042582](https://doi.org/10.1161/JAHA.125.042582). Epub 2026 Feb 20. PMID: 41717916. PMCID: PMC13055806.  

  28. Razavi AC, Bhatia HS, Marrero N, Dzaye O, Post WS, Nasir K, Tsai M, Vaccarino V, Vasan RS, Thanassoulis G, Tsimikas S, Sperling LS, Budoff MJ, Blumenthal RS, Blaha MJ, Whelton SP. Aspirin use, lipoprotein (a), and calcific aortic valve disease: the Multi-ethnic Study of Atherosclerosis. Eur Heart J. 2026 Sep 8;47(34):4792-4801. doi:[10.1093/eurheartj/ehag018](https://doi.org/10.1093/eurheartj/ehag018). Epub 2026 Feb 21. PMID: 41721439. PMCID: PMC13333247. 

  29. Bhatia HS, Fan Y, Dharmavaram G, Razavi AC, Tsai MY, Ramsis M, Mahmud E, Wilkinson M, Taub P, Nasir K, Blaha MJ, Wong ND. Use of Coronary Artery Calcium Scoring in Individuals With Elevated Lipoprotein (a) A Multicohort Study. J Am Coll Cardiol. 2026 May 26;87(20):2864-2872. doi:[10.1016/j.jacc.2026.02.5067](https://doi.org/10.1016/j.jacc.2026.02.5067). Epub 2026 Mar 16. PMID: 41837904. PMCID: PMC13221166. 

  30. Naguib M, Fascetti AJ, Ross EG, Wang EJ, Wilkinson M, Mahmud E, Taub P, Bhatia HS, Ramsis M. Marked Underutilization of Lipoprotein (a) Testing in Peripheral Artery Disease: A National Analysis of 8.3 Million Patients. Am J Prev Cardiol. 2026 Apr 9;27:101628. doi:[10.1016/j.ajpc.2026.101628](https://doi.org/10.1016/j.ajpc.2026.101628). Epub 2026 Apr 9. PMID: 42291072. PMCID: PMC13261232. 

  31. Chadha S, Dharmavaram G, Martinez B, Mahmud A, Adler D, Cuomo R, Bhatia HS, Ramsis M, Wilkinson MJ, Meyer BC, Taub PR. High Prevalence of Vascular Calcification in Young Stroke Patients. Am J Prev Cardiol. 2026 Apr 20;27:101647. doi:[10.1016/j.ajpc.2026.101647](https://doi.org/10.1016/j.ajpc.2026.101647). Epub 2026 Apr 20. PMID: 42291024. PMCID: PMC13261255. 

  32. Wolfe R, Bhatia H, Lacaze P, Orchard SG, Owen A, Polekhina G, Yu C, Woods RL, Tonkin A, Tsimikas S. The role of Lipoprotein (a) and oxidized phospholipids in modifying the effects of aspirin on major cardiovascular events and bleeding in the ASPirin in Reducing Events in the …. medRxiv [Preprint]. 2026 May 20:2026.05.17.26353443. doi:[10.64898/2026.05.17.26353443](https://doi.org/10.64898/2026.05.17.26353443). Epub 2026 May 20. PMID: 42238436. PMCID: PMC13228837. [Preprint]  

  33. McParland J, Rikhi R, Bhatia HS, Razavi AC, Chevli P, Mirzai S, Spitz JA, Sharma G, Khan MS, Slipczuk L, Dalakoti M, Blaha MJ, Blumenthal RS, Shapiro MD. Comparative associations of LDL-C, Lp (a), hsCRP, and IL-6 with cardiovascular risk: Insights from the United Kingdom (UK) biobank and the multi-ethnic study of atherosclerosis …. Prog Cardiovasc Dis. 2026 May 22:S0033-0620(26)00046-0. doi:[10.1016/j.pcad.2026.05.005](https://doi.org/10.1016/j.pcad.2026.05.005). Epub 2026 May 22. PMID: 42173333.  

  34. Petek BJ, Ajufo E, Churchill TW, Guseh JS, Moulson N, Bhatia HS, Shapiro MD, Ellinor PT, Khurshid S. Cardiovascular Risk Prediction Across the Spectrum of Measured Physical Activity. J Am Coll Cardiol. 2026 Jul 21;88(3):356-359. doi:[10.1016/j.jacc.2026.04.024](https://doi.org/10.1016/j.jacc.2026.04.024). Epub 2026 May 27. PMID: 42201281.  

  35. Dharmavaram G, Chadha S, McLaren G, Martinez B, Mahmud A, Adler D, Cuomo R, Bhatia HS, Ramsis M, Wilkinson MJ, Meyer BC, Taub PR. Incidental Steatotic Liver in Young Ischemic Stroke Patients: A Marker of High Vascular Burden and Underrecognized Prevention Opportunity. J Clin Lipidol. 2026 Sep;20(9):2051-2055. doi:[10.1016/j.jacl.2026.07.010](https://doi.org/10.1016/j.jacl.2026.07.010). Epub 2026 Jul 9. PMID: 42532706.  

  36. Rikhi R, Chen H, Mirzai S, Bhatia HS, Ashburn NP, O'Connor S, Chevli PA, Kazibwe R, Khan MS, Sharma G, Slipczuk L, Al-Kindi S, Nasir K, Post WS, Blumenthal RS, Shapiro MD. The Role of Coronary Artery Calcium in Statin Eligibility Based on the American Heart Association’s PREVENT Calculator: Insights From MESA. J Am Coll Cardiol. 2026 Aug 18;88(7):739-748. doi:[10.1016/j.jacc.2026.05.039](https://doi.org/10.1016/j.jacc.2026.05.039). Epub 2026 Jul 15. PMID: 42455102. 

  37. Ocher R, Cuomo R, Bhatia HS, Ramsis M, Mahmud E, Taub PR, Wilkinson MJ. Elevated Lipoprotein (a) Is Highly Prevalent in Autoimmune or Inflammatory Disease: A Multisite Study. JACC Adv. 2026 Aug;5(8):103039. doi:[10.1016/j.jacadv.2026.103039](https://doi.org/10.1016/j.jacadv.2026.103039). Epub 2026 Aug 26. PMID: 42657849. PMCID: PMC13531624.  

  38. Khedagi A, Razavi AC, Blumenthal RS, Tsai M, Blaha MJ, Dzaye O, Bhatia HS. Modeled Age and Interval for CAC Detection in Adults with Elevated Lipoprotein (a): Insights From MESA. Am J Prev Cardiol. 2026 Sep 5:101815. Online ahead of print. doi:[10.1016/j.ajpc.2026.101815](https://doi.org/10.1016/j.ajpc.2026.101815). Epub 2026 Sep 5.  

  39. Bal KS, Reyes MP, Kanaya AM, Taub P, Tsai MY, Kandula NR, Islam N, Wilkinson MJ, Ramsis M, Mahmud E, Shah NS, Kulkarni A, Kalra D, Bhatia HS. Lipoprotein(a) in Disaggregated South Asian Groups: An Analysis of MASALA and the UK Biobank. JACC Adv. 2026 Oct 13:103329. doi:[10.1016/j.jacadv.2026.103329](https://doi.org/10.1016/j.jacadv.2026.103329). Epub 2026 Oct 13. PMID: 42868967. PMCID: PMC13685961. 


 

Editorials & Reviews

  1. Bhatia HS, Wilkinson MJ. Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies. J Clin Med. 2022 Oct 13;11(20):6040. doi:[10.3390/jcm11206040](https://doi.org/10.3390/jcm11206040). PMID: 36294361. PMCID: PMC9604626.  

  2. Bhatia HS. Aspirin and lipoprotein(a) in primary prevention. Curr Opin Lipidol. 2023 Oct 1;34(5):214-220. doi:[10.1097/MOL.0000000000000891](https://doi.org/10.1097/MOL.0000000000000891). Epub 2023 Jul 31. PMID: 37527183. PMCID: PMC11216950. 

  3. Ma GS, Chiou TT, Wilkinson MJ. Is Lipoprotein(a) Clinically Actionable with Today's Evidence? The Answer is Yes. Curr Cardiol Rep. 2023 Oct;25(10):1175-1187. doi:[10.1007/s11886-023-01937-z](https://doi.org/10.1007/s11886-023-01937-z). Epub 2023 Aug 26. PMID: 37632608. PMCID: PMC10651710.  

  4. Bhatia HS, Becker RC, Leibundgut G, Patel M, Lacaze P, Tonkin A, Narula J, Tsimikas S. Lipoprotein(a), platelet function and cardiovascular disease. Nat Rev Cardiol. 2024 May;21(5):299-311. doi:[10.1038/s41569-023-00947-2](https://doi.org/10.1038/s41569-023-00947-2). Epub 2023 Nov 8. PMID: 37938756. PMCID: PMC11216952.  

  5. Blaha MJ, Bhatia HS. Lipoprotein(a), Residual Cardiovascular Risk, and the Search for Targeted Therapy. J Am Coll Cardiol. 2024 Apr 23;83(16):1540-1542. doi:[10.1016/j.jacc.2024.03.370](https://doi.org/10.1016/j.jacc.2024.03.370). Epub 2024 Mar 25. PMID: 38537912. PMCID: PMC11216951. 

  6. Koschinsky ML, Bajaj A, Boffa MB, Dixon DL, Ferdinand KC, Gidding SS, Gill EA, Jacobson TA, Michos ED, Safarova MS, Soffer DE, Taub PR, Wilkinson MJ, Wilson DP, Ballantyne CM. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol. 2024 May-Jun;18(3):e308-e319. doi:[10.1016/j.jacl.2024.03.001](https://doi.org/10.1016/j.jacl.2024.03.001). Epub 2024 Apr 1. PMID: 38565461. [Scientific statement]  

  7. Ellberg CC, Bhatia HS. Strategies for management of patients with elevated lipoprotein(a). Curr Opin Lipidol. 2024 Oct 1;35(5):234-240. doi:[10.1097/MOL.0000000000000950](https://doi.org/10.1097/MOL.0000000000000950). Epub 2024 Aug 14. PMID: 39145610. PMCID: PMC11387124.  

  8. Bhatia HS, Boccara F. Lipoprotein(a): Don't forget about secondary prevention. Eur J Prev Cardiol. 2024 Nov 11;31(15):1888-1889. doi:[10.1093/eurjpc/zwae276](https://doi.org/10.1093/eurjpc/zwae276). Epub 2024 Aug 21. PMID: 39166475. 

  9. Razavi AC, Blaha MJ, Bhatia HS. Inconsistent association between lipoprotein(a) and coronary artery calcium. Eur J Prev Cardiol. 2025 Jul 14;32(9):756-757. doi:[10.1093/eurjpc/zwaf196](https://doi.org/10.1093/eurjpc/zwaf196). Epub 2025 Apr 8. PMID: 40194782. PMCID: PMC12259357. 

  10. Razavi AC, Bhatia HS. Role of Aspirin in Reducing Risk for Atherosclerotic Cardiovascular Disease in Individuals with Elevated Lipoprotein(a). Curr Atheroscler Rep. 2025 Apr 8;27(1):49. doi:[10.1007/s11883-025-01296-w](https://doi.org/10.1007/s11883-025-01296-w). Epub 2025 Apr 8. PMID: 40198456. PMCID: PMC12122059.  

  11. Wong ND, Bhatia HS, Nasir K. Lipoprotein(a) and Atherosclerosis: Not So Little Anymore With Bigger Data. J Am Coll Cardiol. 2025 Jun 3;85(21):1993-1995. doi:[10.1016/j.jacc.2025.03.504](https://doi.org/10.1016/j.jacc.2025.03.504). Epub 2025 Apr 23. PMID: 40266172.  

  12. Razavi AC, Bhatia HS, Blumenthal RS, Shapiro MD, Mehta A. Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications. Diabetes Obes Metab. 2025 Sep;27 Suppl 8:34-46. doi:[10.1111/dom.16469](https://doi.org/10.1111/dom.16469). Epub 2025 May 28. PMID: 40437821. PMCID: PMC12354239.  

  13. Bhatia HS, Dalal S, Ross E. Peripheral arterial disease associated with elevated lipoprotein(a): a review of the evidence and treatment approaches. Curr Opin Lipidol. 2025 Oct 1;36(5):238-250. doi:[10.1097/MOL.0000000000000999](https://doi.org/10.1097/MOL.0000000000000999). Epub 2025 Jun 13. PMID: 40511686. PMCID: PMC12353575. 

  14. Bhatia HS, Bajaj A, Goonewardena SN, Moriarty PM. Pelacarsen: Mechanism of action and Lp(a)-lowering effect. J Clin Lipidol. 2025 Sep-Oct;19(5):1208-1222. doi:[10.1016/j.jacl.2025.06.004](https://doi.org/10.1016/j.jacl.2025.06.004). Epub 2025 Jun 16. PMID: 40781022. 

  15. Razavi AC, Hong J, Bhatia HS. Lp (a): Global Public Health Concern: Emerging Knowledge and Therapeutic Approaches. Curr Cardiol Rep. 2025 Jun 25;27(1):104. doi:[10.1007/s11886-025-02255-2](https://doi.org/10.1007/s11886-025-02255-2). Epub 2025 Jun 25. PMID: 40560311. 

  16. Bhatia HS, Aboyans V. EJPC @ a Glance: Lipoprotein(a): new insights on an old enemy. Eur J Prev Cardiol. 2025 Jul 14;32(9):713-715. doi:[10.1093/eurjpc/zwaf312](https://doi.org/10.1093/eurjpc/zwaf312). Epub 2025 Jul 14. PMID: 40654286.  

  17. Patel D, Koschinsky ML, Agarwala A, Natarajan P, Bhatia HS, Mehta A, Patel J, Peters M, Pandya S, Sagheer U, Puri R, Virani SS, Kalra DK. Role of Lipoprotein(a) in Atherosclerotic Cardiovascular Disease in South Asian Individuals. J Am Heart Assoc. 2025 Jul 15;14(14):eJAHA2024040361T. doi:[10.1161/JAHA.124.040361](https://doi.org/10.1161/JAHA.124.040361). Epub 2025 Jul 14. PMID: 40654252. 

  18. Razavi AC, Whelton SP, Bhatia HS. Interpreting Elevated Lipoprotein(a) According to Baseline Atherosclerotic Cardiovascular Disease Risk. Eur J Prev Cardiol. 2025 Jul 15:zwaf421. doi:[10.1093/eurjpc/zwaf421](https://doi.org/10.1093/eurjpc/zwaf421). Epub 2025 Jul 15. PMID: 40662564. 

  19. Ahlers M, John S, Bhatia H, Le V, Taub P. Identification and management of patients at highrisk for cardiovascular disease in primary prevention. Am J Prev Cardiol. 2025 Aug 22;23:101265. doi:[10.1016/j.ajpc.2025.101265](https://doi.org/10.1016/j.ajpc.2025.101265). Epub 2025 Aug 22. PMID: 40932828. PMCID: PMC12418864.  

  20. Bhatia HS. Lipoprotein(a) at a "Tipping Point": case to move to universal screening. Am J Prev Cardiol. 2025 Aug 22;23:101274. doi:[10.1016/j.ajpc.2025.101274](https://doi.org/10.1016/j.ajpc.2025.101274). Epub 2025 Aug 22. PMID: 40918925. PMCID: PMC12409449. 

  21. Bhatia HS, Michos ED. Elevated lipoprotein(a) in adverse pregnancy outcomes - Chicken or egg?. Prog Cardiovasc Dis. 2025 Sep-Oct;92:180-181. doi:[10.1016/j.pcad.2025.09.001](https://doi.org/10.1016/j.pcad.2025.09.001). Epub 2025 Sep 4. PMID: 40914485. 

  22. Bhatia HS, Mehta A. Lipoprotein (a) Elevation for Refining Risk Stratification With the PREVENT Equations—Reply. JAMA Cardiol. 2026 Jan 1;11(1):107-108. doi:[10.1001/jamacardio.2025.4453](https://doi.org/10.1001/jamacardio.2025.4453). Epub 2026 Jan 1. PMID: 41369939. [Correspondence / reply] 

  23. Allen TS, Bhatia HS, Allison MA. Long-term Risk Assessment in Primary Prevention: Making the Case for 30-Year PREVENT Scores. Eur J Prev Cardiol. 2026 Feb 6:zwag062. doi:[10.1093/eurjpc/zwag062](https://doi.org/10.1093/eurjpc/zwag062). Epub 2026 Feb 6. PMID: 41649907.  

  24. Sebastian SA, Bimal T, Ayyalu T, Vartak N, Bhatia HS, Tsimikas S. Association of Lp (a) With Coronary Plaque Burden and High-Risk Plaque Features: A Meta-Analysis of Imaging Studies. Atherosclerosis. 2026 Apr;415:120706. doi:[10.1016/j.atherosclerosis.2026.120706](https://doi.org/10.1016/j.atherosclerosis.2026.120706). Epub 2026 Mar 13. PMID: 41850136. PMCID: PMC13326733. [Meta-analysis] 

  25. Kermanshahchi J, Bhatia HS. First Presentation of Atherosclerotic Cardiovascular Disease in Previously Healthy Individuals. Curr Cardiol Rep. 2026 Mar 21;28(1):37. doi:[10.1007/s11886-026-02354-8](https://doi.org/10.1007/s11886-026-02354-8). Epub 2026 Mar 21. PMID: 41863680. 

  26. Bhatia HS. The cardiovascular risk continuum: Continuing to challenge the primary and secondary prevention dichotomy. Am J Prev Cardiol. 2026 Apr 23;28:101644. doi:[10.1016/j.ajpc.2026.101644](https://doi.org/10.1016/j.ajpc.2026.101644). Epub 2026 Apr 23. PMID: 42404864. PMCID: PMC13330693.  

  27. Wilkinson MJ, Koschinsky ML. It's Time to Test All Adults for Lipoprotein(a). J Clin Lipidol. 2026 Sep;20(9 Suppl):7-10. doi:[10.1016/j.jacl.2026.04.022](https://doi.org/10.1016/j.jacl.2026.04.022). Epub 2026 Apr 27. PMID: 42135181. 

  28. Raygani S, Wilkinson MJ. Emerging Therapies to Lower Lipoprotein(a) and the Current Clinical Trials Landscape: RNA-Therapeutics and Beyond. J Clin Lipidol. 2026 Jul 3:S1933-2874(26)00425-3. doi:[10.1016/j.jacl.2026.06.025](https://doi.org/10.1016/j.jacl.2026.06.025). Epub 2026 Jul 3. PMID: 42521529.  

  29. Savides MT, Bhatia HS, Kuznetsova I, Wilkinson MJ. The Evolving Role of Coronary Artery Imaging in Assessing Cardiovascular Risk from Lipoprotein (a). Curr Atheroscler Rep. 2026 Jul 10;28(1):69. doi:[10.1007/s11883-026-01440-0](https://doi.org/10.1007/s11883-026-01440-0). Epub 2026 Jul 10. PMID: 42429866. PMCID: PMC13354612. 

  30. Taub PR, Bhatia HS. Two to Tango: lipoprotein (a) and hormonal status as determinants of venous thromboembolism risk. Eur Heart J. 2026 Jul 14;47(27):3588-3590. doi:[10.1093/eurheartj/ehag263](https://doi.org/10.1093/eurheartj/ehag263). Epub 2026 Jul 14. PMID: 41903522. PMCID: PMC13364078. 

  31. Safarova MS, Sperling L, Mehta A, Bhatia HS, Rodriguez F. The role of lipoprotein (a) in premature cardiovascular disease: primed for prevention. Eur J Prev Cardiol. 2026 Aug 4:zwag313. doi:[10.1093/eurjpc/zwag313](https://doi.org/10.1093/eurjpc/zwag313). Epub 2026 Aug 4. PMID: 42547852.  

  32. Khedagi A, Gong Y, Dharmavaram G, Bhatia HS. Lipoprotein(a) and subclinical atherosclerosis. J Clin Lipidol. 2026 Sep 2:S1933-2874(26)00497-6. doi:[10.1016/j.jacl.2026.08.025](https://doi.org/10.1016/j.jacl.2026.08.025). Epub 2026 Sep 1. PMID: 42728124. 

  33. Shahid I, Bhatia HS. Very Low Lipoprotein (a) and Type 2 Diabetes: Implications for Ongoing Clinical Trials. Am J Prev Cardiol. 2026:101793. Online ahead of print. doi:[10.1016/j.ajpc.2026.101793](https://doi.org/10.1016/j.ajpc.2026.101793). 

  34. Wong ND, Bhatia HS. Is Lipoprotein (a) Still Relevant or a “Lost Horizon”?. Am J Prev Cardiol. 2026:101830. Online ahead of print. doi:[10.1016/j.ajpc.2026.101830](https://doi.org/10.1016/j.ajpc.2026.101830).